Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3040668	b-dm2alld	— (—)	148	149	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Symptoms and signs involving the nervous and musculoskeletal systems

20.51

116.04

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

26.98

114.26

1.0

—

Diseases of the myoneural junction and muscle

27.87

69.36

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

10.39

47.96

1.0

—

Myalgia

30.08

29.36

1.0

—

Pain in limb

7.50

26.17

1.0

—

Pain in joint

10.06

24.42

1.0

—

Soft tissue disorders

6.40

22.47

1.0

—

Other and unspecified myopathies

30.20

20.54

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

7.50

19.90

1.0

—

Neurological diseases

7.95

19.78

1.0

—

Spondylosis

6.79

19.23

1.0

—

Spondylopathies

5.66

19.17

1.0

—

Dorsalgia

4.99

17.62

1.0

—

Fibromyalgia

35.15

16.65

1.0

—

Other specific joint derangements/joint disorders

4.87

16.60

1.0

—

Shoulder lesions

5.99

16.20

1.0

—

Codeine

4.47

14.27

1.0

—

Asthma

4.44

13.87

1.0

—

Other dorsopathies, not elsewhere classified

4.38

13.72

1.0

—

Other intervertebral disc disorders

4.62

13.67

1.0

—

Low back pain

4.63

13.28

1.0

—

Asthma (mode)

4.31

12.93

1.0

—

Asthma, excluding more controls

4.30

12.76

1.0

—

Nerve, nerve root and plexus disorders

3.40

12.57

1.0

—

Inflammatory bowel disease treatment related agents

3.38

12.56

1.0

—

Dyspnoea

3.53

12.44

1.0

—

Codeine or tramadol medication

3.46

12.42

1.0

—

Oral corticosteroids

3.37

12.06

1.0

—

Asthma, unspecified (mode), excluding more controls

4.77

12.05

1.0

—

Malaise and fatigue

5.06

11.98

1.0

—

Diseases of the musculoskeletal system and connective tissue

8.49

11.96

1.0

—

Dorsopathies

4.07

11.95

1.0

—

Disorders of synovium and tendon

6.02

11.95

1.0

—

Chronic lower respiratory diseases

3.22

11.93

1.0

—

Asthma, unspecified (mode)

4.71

11.91

1.0

—

Intracranial trauma

7.09

11.86

1.0

—

Rheumatism, unspecified

30.06

11.63

1.0

—

Other antidepressants

3.61

11.60

1.0

—

Asthma (only as main-diagnosis), excluding more controls

4.18

11.54

1.0

—

Asthma (only as main-diagnosis)

4.14

11.47

1.0

—

General symptoms and signs

3.48

11.46

1.0

—

Asthma, including avohilmo

3.17

11.45

1.0

—

Pain (limb, back, neck, head abdominally)

5.88

11.30

1.0

—

Persons encountering health services in other circumstances, wide

3.28

11.28

1.0

—

Sleep apnoea

3.38

11.19

1.0

—

Abnormalities of breathing

3.78

10.94

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.25

10.88

1.0

—

GASTRO-related operations

4.28

10.79

1.0

—

Any gastric operation

4.28

10.79

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

5.25

10.67

1.0

—

Asthma/COPD (KELA code 203)

3.27

10.64

1.0

—

Opioids

3.80

10.58

1.0

—

Obesity related asthma

4.80

10.46

1.0

—

Asthma (diagnoses ohter than nonallergic)

103

3.21

10.25

1.0

—

Migraine

4.50

10.11

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.16

9.95

1.0

—

ILD medications

3.13

9.91

1.0

—

Abnormalities of gait and mobility

26.05

9.80

1.1

1.0

—

Used for control exclusion in common control thyroid runs

3.34

9.74

1.0

—

Episodal and paroxysmal disorders

3.38

9.72

1.0

—

Asthma-related infections

3.77

9.68

1.0

—

Asthma, hospital admission 2, infections

3.77

9.68

1.0

—

Pain, not elsewhere classified

7.79

9.59

1.0

—

First line medication for Crohn's disease

3.14

9.57

1.0

—

Cervical disc disorders

7.10

9.47

1.0

—

Myositis

+∞

9.39

1.1

0.0

—

Medical observation and evaluation for suspected diseases and conditions

4.92

9.38

1.0

—

Concussion

8.14

9.35

1.0

—

Rotator cuff syndrome

5.05

9.27

1.0

—

Sciatica+with lumbago

4.64

9.27

1.0

—

Depression or dysthymia

4.37

9.20

1.0

—

Tramadol

3.77

9.17

1.0

—

Other functional intestinal disorders

4.06

9.03

1.0

—

Major coronary heart disease event

3.11

8.70

1.0

—

Sleep apnoea, including avohilmo

2.95

8.66

1.0

—

Lower back pain or/and sciatica

102

2.80

8.55

1.0

—

Parasetamol

4.07

8.53

1.0

—

Asthma, hospital admissions , main diagnosis only

107

3.01

8.52

1.0

—

Hard cardiovascular diseases

3.11

8.49

1.0

—

Disorders of muscles

20.04

8.46

1.1

1.0

—

Finngen Rheumatological endpoints

3.07

8.39

1.0

—

Other joint disorders

3.35

8.36

1.0

—

Autoimmune diseases

2.94

8.29

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

3.23

8.24

1.0

—

Hyperlipidaemia, other/unspecified

4.50

8.18

1.1

1.0

—

Pain in throat and chest

3.37

8.09

1.0

—

Other headache syndromes

4.33

8.09

1.0

—

Endocrine, nutritional and metabolic diseases

3.59

8.07

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

3.08

8.01

1.0

—

Care involving use of rehabilitation procedures

3.25

7.92

1.0

—

Autoimmune diseases excluding thyroid diseases

2.92

7.86

1.0

—

Metabolic disorders

2.83

7.69

1.0

—

Spinal stenosis

4.47

7.61

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

11.47

7.60

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.95

7.43

1.0

—

Hypertensive diseases (excluding secondary)

3.65

7.38

1.0

—

Percutaneous Coronary Intervention

2.96

7.33

1.0

—

Sleep disorders (combined)

2.82

7.32

1.0

—

Coronary revascularization (ANGIO or CABG)

2.95

7.32

1.0

—

Other enthesopathies

9.34

7.27

1.0

—

Disorders of other endocrine glands

3.59

7.24

1.0

—

Persons encountering health services for specific procedures and health care

2.62

7.20

1.0

—

Persons encountering health services for examination and investigation

4.27

7.15

1.0

—

Cardiovascular diseases

3.98

7.05

1.0

—

Ischemic heart diseases

2.90

7.04

1.0

—

Recurrent or chronic depression

4.39

6.95

1.0

—

3.58

6.91

1.0

—

Abnormal findings on examination of blood, without diagnosis

3.53

6.91

1.0

—

Implicit Sepsis

2.95

6.87

1.0

—

Emergency coronary revascularization (for ACS)

2.76

6.70

1.0

—

Other systemic involvement of connective tissue (FG)

6.55

6.69

1.1

1.0

—

Antihypertensive medication - note that there are other indications

3.80

6.64

1.0

—

Nausea and vomiting

6.97

6.56

1.0

—

Excessive, frequent and irregular menstruation

5.04

6.45

1.0

1.1

—

Deforming dorsopathies

6.16

6.45

1.0

—

Arthropathies

2.98

6.42

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.59

6.41

1.0

—

Anxiety disorders, excluding more controls

2.78

6.39

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.63

6.36

1.0

—

Second line medication for Crohn's disease

2.96

6.34

1.0

—

Disturbances of skin sensation

4.05

6.34

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

11.05

6.29

1.0

—

Lumbar disc prolapse

3.54

6.29

1.0

—

Systemic connective tissue disorders

3.83

6.25

1.1

1.0

—

Depression medications

8.38

6.24

1.0

—

Mood disorders, excluding more controls

2.62

6.09

1.0

—

Abnormal involuntary movements

12.52

6.07

1.0

—

Coxarthrosis

3.66

6.01

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.09

5.99

1.0

—

Procreative management

3.80

5.86

1.0

—

ILD medications: immunosuppressive drugs

2.98

5.81

1.0

—

Acute upper respiratory infections

2.50

5.77

1.0

—

Implicit Sepsis, including avohilmo

2.62

5.75

1.0

—

Diseases of the eye and adnexa

2.88

5.72

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

2.69

5.72

1.0

—

Diseases of the respiratory system

3.49

5.65

1.0

—

Polyarthrosis

6.89

5.64

1.0

1.1

—

Other reaction to severe stress, and adjustment disorders

3.39

5.56

1.1

1.0

—

Migraine without aura

6.50

5.54

1.0

1.1

—

Benign neoplasms

2.52

5.54

1.0

—

Diseases of the skin and subcutaneous tissue

2.58

5.51

1.0

—

Other and unspecified dermatitis

2.99

5.51

1.0

—

L04AX Other immunosuppressants

2.81

5.38

1.0

—

Fitting and adjustment of other devices

3.65

5.36

1.0

—

Hypertension, essential

2.56

5.34

1.0

—

Hypertensive diseases

2.56

5.32

1.0

—

Hypertension

2.56

5.32

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.51

5.28

1.0

—

Constipation

2.48

5.26

1.0

—

Symptoms and signs involving the digestive system and abdomen

2.58

5.22

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

107

2.56

5.18

1.0

—

Triptan medication for migraine, min. 3 purchases

2.83

5.10

1.0

—

Dermatitis and eczema

107

2.27

5.10

1.0

—

Coxarthrosis [arthrosis of hip](FG)

3.09

5.07

1.0

—

Depression

106

2.33

5.05

1.0

—

Extrapyramidal and movement disorders

3.27

5.01

1.0

—

Any mental disorder

2.35

5.01

1.0

—

Hypothyroidism and >3 levothyroxin purchases

7.47

4.96

1.0

—

Hypothyroidism, levothyroxine purchases

7.47

4.96

1.0

—

Hypothyroidism (congenital or acquired)

7.47

4.95

1.0

—

Persons encountering health services in other circumstances

3.36

4.92

1.0

—

Other systemic involvement of connective tissue

4.33

4.92

1.1

1.0

—

Injury, poisoning and certain other consequences of external causes

3.46

4.87

1.1

1.0

—

Mood [affective] disorders

107

2.27

4.87

1.0

—

Mood disorders

107

2.27

4.85

1.0

—

Contact with and exposure to communicable diseases

3.46

4.84

1.0

—

Persons with potential health hazards related to communicable diseases

3.19

4.80

1.0

—

Undetermined asthma

9.00

4.77

1.0

—

Undetermined asthma, excluding more controls

9.00

4.77

1.0

—

2.34

4.75

1.0

—

Cervicalgia

5.72

4.74

1.0

—

Acute bronchitis

3.15

4.71

1.1

1.0

—

Bronchitis

101

2.26

4.71

1.0

—

Abnormalities of heart beat

4.41

4.71

1.1

1.0

—

Disorders of eyelid, lacrimal system and orbit

100

2.34

4.55

1.0

—

Adhesive capsulitis of shoulder

10.01

4.51

1.0

—

Triptan medication for migraine, single purchase ok

2.39

4.49

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

2.39

4.49

1.0

—

Carpal tunnel syndrome

2.69

4.48

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

2.86

4.45

1.0

—

Abdominal and pelvic pain

2.43

4.44

1.0

—

Gastrointestinal diseases

3.10

4.40

1.0

—

Haemorrhage from respiratory passages

4.79

4.39

1.0

—

Oxycodone

4.14

4.37

1.0

—

Oedema, not elsewhere classified

4.27

4.32

1.0

—

Other and unspecified polyneuropathies, also in other diseases

5.01

4.31

1.0

—

Neurotic, stress-related and somatoform disorders

105

2.23

4.28

1.0

—

Cramp and spasm

11.70

4.27

1.0

—

Heart failure, not strict

2.44

4.27

1.0

—

Anaemias

7.12

4.24

1.0

—

Anxiety disorders

105

2.22

4.24

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

4.49

4.24

1.0

—

Urinary track infection

2.90

4.18

1.0

—

Injuries to the ankle and foot

107

2.31

4.17

1.0

—

Autoimmune diseases related-to ILD

115

2.25

4.17

1.0

—

Other arthrosis

3.09

4.16

1.0

—

COPD differential diagnosis

2.61

4.12

1.0

—

ILD differential diagnosis

2.61

4.12

1.0

—

Selective serotonin reuptake inhibitors

2.40

4.11

1.0

—

Hypothyroidism, strict autoimmune

2.72

4.10

1.0

—

Syncope and collapse

3.30

4.06

1.0

—

Hypopituitarism

8.01

4.06

1.0

—

Migraine without aura and triptan purchases

4.62

4.05

1.0

—

Other shoulder lesions

10.01

4.01

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

104

2.09

4.00

1.0

—

Other pulmonary diagnosis

2.55

3.98

1.0

—

Excluding asthma or asthma-COPD overlap

2.55

3.98

1.0

—

Psychiatric diseases

2.26

3.97

1.0

—

Asthma-related pneumonia

3.88

3.97

1.1

1.0

—

Asthma, hospital admissions 3, pneumonia

3.88

3.97

1.1

1.0

—

Asthma-related pneumonia or sepsis

3.88

3.97

1.1

1.0

—

Umbilical hernia

3.26

3.90

1.0

—

Benign lipomatous neoplasm

3.26

3.90

1.1

1.0

—

Headache

2.57

3.87

1.0

—

Benzodiazepine use

112

2.11

3.87

1.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

4.33

3.85

1.0

—

Temporomandibular joint disorders, including avohilmo

2.77

3.81

1.0

—

Cardiac arrhythmias

2.61

3.79

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

107

2.10

3.78

1.0

—

Dermatitis

2.42

3.76

1.0

—

Fever of other and unknown origin

2.78

3.76

1.1

1.0

—

Gastro-oesophageal reflux disease

2.31

3.74

1.0

—

Other/unspecified dorsalgia

3.89

3.73

1.0

—

Cystitis

2.31

3.72

1.0

—

Primary hyperparathyroidism

6.68

3.67

1.0

1.1

—

Disorders of lacrimal system

2.79

3.66

1.0

—

Soft tissue disorders related to use, overuse and pressure

5.63

3.65

1.0

—

Pure hypercholesterolaemia

2.32

3.57

1.0

—

Lateral epicondylitis

7.78

3.55

1.0

—

Injury of eye and orbit

4.77

3.55

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

2.37

3.52

1.0

—

Deviated nasal septum

3.04

3.51

1.0

—

Impingement syndrome of shoulder

6.16

3.50

1.0

—

Trochanteric bursitis

10.01

3.49

1.0

—

Hypertrophy of breast in women and men

3.61

3.49

1.0

—

Other diseases of intestines

2.05

3.48

1.0

—

Other diseases of upper respiratory tract

2.08

3.45

1.0

—

Noninflammatory disorders of female genital tract

3.63

3.41

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

109

2.04

3.39

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

2.21

3.38

1.0

—

Polyarthropathies

2.57

3.37

1.0

—

Spondylolisthesis/Spondylolysis

5.00

3.36

1.0

—

Coxarthrosis, primary

2.42

3.35

1.0

—

Heartburn

5.72

3.34

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

101

2.21

3.32

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

2.13

3.32

1.0

—

Implicit viral Sepsis, including avohilmo

3.63

3.27

1.0

—

Acetic acid derivatives and related substances

5.82

3.27

1.0

—

Other heart diseases

2.66

3.25

1.1

1.0

—

Arthrosis

2.50

3.23

1.0

—

Heart failure and coronary heart disease

3.50

3.21

1.1

1.0

—

Heart failure,strict

2.79

3.21

1.1

1.0

—

ILD medications: azathioprine

5.34

3.19

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

111

1.99

3.18

1.0

—

Other noninfective gastroenteritis and colitis

3.79

3.17

1.0

—

Other diseases of urinary system

2.04

3.17

1.0

—

Injuries to the head

110

1.94

3.17

1.0

—

Hypothyroidism, other/unspecified

2.11

3.16

1.0

—

Diseases of liver

2.62

3.12

1.0

—

Paroxysmal tachycardia

3.81

3.11

1.1

1.0

—

Hypertrophy of breast

3.67

3.08

1.0

—

Other extrapyramidal and movement disorders in other diseases

3.67

3.08

1.0

—

Exclusions for E4_PCOS_BROAD

3.67

3.08

1.0

—

Vocal cord dysfunction

6.16

3.05

1.0

—

Trigger finger

7.51

3.05

1.0

—

Brachial plexus disorders

5.01

3.05

1.0

—

Noninfective enteritis and colitis

2.43

3.03

1.0

—

Benign neoplasm: Colon

2.38

3.02

1.1

1.0

—

Radiculopathy

5.84

3.02

1.0

—

Other degenerative diseases of the nervous system

6.38

3.01

1.0

—

Male infertility

10.02

2.98

1.0

—

Other disorders of lacrimal gland

2.75

2.98

1.0

—

Calcific tendinitis of shoulder

10.02

2.98

1.0

—

Other neurological diseases

2.16

2.98

1.0

—

Migraine with aura

3.85

2.97

1.0

—

Other disorders of ear

101

1.98

2.97

1.0

—

Certain infectious and parasitic diseases, including avohilmo

2.30

2.94

1.0

—

Azathioprine

4.71

2.91

1.1

1.0

—

Pain in thoracic spine

4.71

2.91

1.0

—

Other symptoms and signs involving the digestive system and abdomen

4.71

2.91

1.1

1.0

—

Type of accident

2.83

2.91

1.0

—

Hyperparathyroidism

4.66

2.88

1.0

—

Genitourinary diseases

2.51

2.88

1.0

—

Dysphagia

3.71

2.87

1.0

—

Other sleep disorders

5.39

2.87

1.0

1.1

—

Disorder of lipoprotein metabolism, unspecified

6.67

2.86

1.0

—

Irregular menses

2.41

2.83

1.0

—

Atrial fibrillation and flutter with reimbursement

3.94

2.82

1.1

1.0

—

Other acute lower respiratory infections

2.29

2.81

1.1

1.0

—

Coxibs

5.25

2.78

1.0

—

External causes of morbidity and mortality

2.34

2.78

1.0

—

Type 2 diabetes, wide definition

2.10

2.78

1.0

—

Gonarthrosis

2.48

2.77

1.0

—

Other disorders of the musculoskeletal system and connective tissue

3.92

2.77

1.1

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

5.01

2.72

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

5.01

2.72

1.0

—

Suggestive for eosinophilic asthma

5.01

2.72

1.0

—

Disorders of sclera, cornea, iris and ciliary body

2.20

2.72

1.0

—

Abnormal serum enzyme levels

3.05

2.72

1.0

—

Blepharochalasis

3.24

2.72

1.0

—

Persons encountering health services in circumstances related to reproduction

2.14

2.72

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

2.71

1.0

—

Use of pramipexole

3.45

2.68

1.0

—

Pacemaker

3.01

2.68

1.0

—

Contraceptive management

2.43

2.66

1.0

—

Oxicams

5.68

2.66

1.0

—

COPD/asthma related infections

1.99

2.66

1.0

—

COPD/asthma/ILD related infections

1.99

2.66

1.0

—

Injuries to the wrist and hand

114

1.86

2.61

1.0

—

Cough

2.95

2.61

1.0

—

Non-invasive ventilation

3.70

2.58

1.0

—

Hyperkinetic disorders, excluding more controls

4.67

2.57

1.0

—

Lesion of ulnar nerve

4.00

2.56

1.1

1.0

—

Diabetes mellitus

1.87

2.56

1.0

—

Disease of hard tissues of teeth, NOS

2.47

2.56

1.1

1.0

—

Irritable bowel syndrome

3.06

2.56

1.0

—

Hypermobility syndrome

5.47

2.54

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

5.46

2.54

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

5.46

2.54

1.0

—

Hypokalaemia

5.46

2.54

1.0

—

Disorders of parathyroid gland

3.56

2.54

1.1

1.0

—

Diabetes medication

105

1.83

2.52

1.0

—

Open wound of wrist and hand

2.28

2.52

1.0

—

Other diseases of hard tissues of teeth

2.45

2.50

1.1

1.0

—

Type 2 diabetes

1.87

2.50

1.0

—

Fracture of foot, except ankle

2.97

2.48

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

3.46

2.48

1.0

—

Enthesopathies of lower limb, excluding foot

3.46

2.48

1.0

—

Female genital prolapse

3.48

2.47

1.0

1.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.50

2.46

1.0

1.1

—

Dizziness and giddiness

1.98

2.44

1.0

—

Conductive and sensorineural hearing loss

1.98

2.43

1.0

—

Ischaemic heart disease, wide definition

1.95

2.41

1.0

—

Disorders of the thyroid gland

1.89

2.41

1.0

—

Hernia of abdominal wall

2.29

2.40

1.0

—

Intracranial injury

2.13

2.40

1.0

—

All-cause Heart Failure

2.37

2.40

1.1

1.0

—

Reimbursement for rheumatic diseases

2.12

2.40

1.0

—

Benign neoplasm: Ascending colon

5.00

2.40

1.2

1.0

—

Polymyalgia rheumatica

5.00

2.40

1.2

1.0

—

Ganglion

5.00

2.40

1.0

—

Other (not insulin) diabetes medications

1.84

2.39

1.0

—

Intestinal infectious diseases

117

1.84

2.38

1.0

—

Benign neoplasm: Rectum, anus and anal canal

3.64

2.36

1.0

—

Other diseases of liver

3.03

2.35

1.0

—

Continuous positive airway pressure

3.70

2.34

1.0

—

Other symptoms and signs involving cognitive functions and awareness

2.33

2.31

1.0

—

Leisure time condition

3.22

2.30

1.0

—

Heart failure, strict

2.32

2.30

1.1

1.0

—

Chronic sinusitis

2.31

2.30

1.0

—

Artrosis, including avohilmo

1.95

2.28

1.0

—

Sensorineural hearing loss

1.95

2.27

1.0

—

Problems related to lifestyle

4.62

2.27

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.84

2.26

1.0

—

Noninfectious colitis NAS

3.89

2.25

1.0

1.1

—

Myocardial infarction, without ST-elevation

2.76

2.25

1.1

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.83

2.24

1.0

—

Type 2 diabetes, definitions combined

1.83

2.24

1.0

—

Other disorders of eyelid

2.36

2.23

1.0

—

Mouth breathing

2.27

2.23

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

2.73

2.23

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.34

2.22

1.0

—

Symptoms and signs concerning food and fluid intake

5.55

2.21

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.36

2.20

1.0

—

Propionic acid derivatives

4.40

2.19

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

4.40

2.19

1.0

—

Gonarthrosis [arthrosis of knee](FG)

2.05

2.19

1.0

—

Diabetes, varying definitions

101

1.78

2.19

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

3.34

2.18

1.1

1.0

—

Benign neoplasm: Sigmoid colon

3.34

2.18

1.1

1.0

—

Vasomotor and allergic rhinitis

2.32

2.17

1.1

1.0

—

Disorders of breast

2.20

2.17

1.0

—

Coronary atherosclerosis

2.10

2.16

1.1

1.0

—

Diabetic maculopathy, excluding more controls

4.29

2.15

1.0

—

Benign neoplasm: Rectum

3.69

2.15

1.0

1.1

—

Dental operations

2.24

2.12

1.1

1.0

—

Heart failure and antihypertensive medication

3.46

2.12

1.1

1.0

—

Internal derangement of knee

2.59

2.11

1.0

—

Disorders of lens

1.93

2.09

1.0

—

Diseases of oral cavity, salivary glands and jaws

2.29

2.09

1.1

1.0

—

5-aminosalicylic acid

3.20

2.09

1.0

—

Dystonia

5.01

2.07

1.0

—

Dermatitis due to substances taken internally

5.01

2.07

1.2

1.0

—

Elevated blood glucose level

5.01

2.07

1.0

—

Benign neoplasm: Colon, unspecified

2.90

2.07

1.1

1.0

—

Other disorders of patella

3.50

2.05

1.0

1.1

—

Unstable angina pectoris

2.95

2.04

1.1

1.0

—

Scleritis and episcleritis

4.01

2.04

1.0

—

Cholelithiasis

1.81

2.02

1.0

—

Obesity due to excess calories

2.11

2.02

1.1

1.0

—

Other hearing loss

3.10

2.02

1.0

—

Presence of other functional implants

2.12

2.01

1.0

—

Coxarthrosis, primary, with hip surgery

2.24

2.01

1.0

—

Fracture at wrist and hand level

2.39

2.00

1.0

—

Maternal care for other conditions predominantly related to pregnancy

2.83

2.00

1.0

—

Hyperkinetic disorders

3.41

2.00

1.0

—

Ovarian cyst

3.03

2.00

1.0

1.1

—

Iridocyclitis

2.81

2.00

1.0

—

Statin medication

1.90

1.99

1.0

—

Certain infectious and parasitic diseases

1.77

1.97

1.0

—

Ulcerative colitis, NAS

3.34

1.96

1.0

—

Diseases of oesophagus, stomach and duodenum

107

1.71

1.95

1.0

—

Cervicocranial syndrome

4.55

1.94

1.0

—

Other specified/unspecified arthritis

2.96

1.93

1.0

—

Examination and observation for other reasons

2.51

1.93

1.0

—

Disorders of conjunctiva

114

1.77

1.93

1.0

—

Myocardial infarction, strict

2.43

1.92

1.0

—

Asthma and allergy

4.49

1.92

1.0

—

Myocardial infarction

2.33

1.92

1.1

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.06

1.91

1.0

—

Other heart diseases, wide

1.75

1.91

1.0

—

Atrial fibrillation and flutter

2.73

1.91

1.1

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.75

1.91

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

2.31

1.87

1.0

—

Osteopathies and chondropathies

1.96

1.87

1.0

—

Acute sinusitis

2.05

1.86

1.0

—

Meniscus derangement

2.21

1.83

1.0

—

Chronic laryngitis and laryngotracheitis

3.53

1.83

1.0

—

Abnormal weight loss

4.17

1.82

1.0

1.1

—

Mixed conductive and sensorineural hearing loss

4.17

1.82

1.0

1.1

—

Any reimbursement code in KELA

2.08

1.80

1.0

—

Ulcerative colitis

2.57

1.80

1.0

—

Other arthritis (FG)

2.57

1.80

1.0

—

Inflammatory disease of uterus

3.05

1.80

1.0

—

Nasal polyp

3.05

1.79

1.0

—

Other respiratory disorders and diseases

3.04

1.79

1.0

—

Other diseases of the respiratory system

3.04

1.79

1.0

—

Other abnormal uterine and vaginal bleeding

3.14

1.77

1.0

1.1

—

Postmenopausal bleeding

2.99

1.77

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

100

1.73

1.77

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2.54

1.77

1.0

—

Other nutritional deficiencies

106

1.81

1.75

1.0

—

Allergic asthma (mode)

2.97

1.75

1.0

—

Allergic asthma (mode), excluding more controls

2.97

1.75

1.0

—

Bitten or struck by other mammals

3.34

1.74

1.0

1.1

—

IBD patients in KELA-register

2.50

1.73

1.0

—

Inflammatory bowel disease

2.22

1.73

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.22

1.73

1.0

—

Biguanides

100

1.69

1.73

1.0

—

Major coronary heart disease event excluding revascularizations

2.03

1.72

1.1

1.0

—

Allergic rhinitis

2.31

1.72

1.0

—

Caries of dentine

2.93

1.72

1.0

—

Restless leg syndrome

2.92

1.72

1.0

—

Episcleritis

3.85

1.71

1.0

—

Weight loss

3.85

1.71

1.0

1.1

—

Disorders of gallbladder, biliary tract and pancreas

104

1.67

1.69

1.0

—

Asthma and allergy, excluding more controls

3.80

1.69

1.0

—

Dentofacial anomalies [including malocclusion]

103

1.75

1.68

1.0

—

Menorrhagia

2.79

1.67

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.67

1.66

1.0

—

Superficial injury of thorax

2.80

1.65

1.0

—

Female infertility

3.00

1.65

1.0

1.1

—

Striking against or struck by other objects

2.09

1.64

1.0

—

Neoplasms

1.80

1.64

1.0

—

Pollen allergy

2.54

1.62

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

3.57

1.61

1.0

1.1

—

Allergic conjunctivitis

1.84

1.61

1.0

—

Gingivitis and periodontal diseases

1.68

1.60

1.0

—

Conjunctivitis

108

1.71

1.59

1.0

—

Cardiomyopathies, Primary/intrinsic

3.00

1.58

1.0

—

Cardiomyopathy (excluding other)

3.00

1.58

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

3.00

1.58

1.2

1.0

—

Other retinal disorders

1.85

1.57

1.0

—

Nutritional anaemias

1.99

1.56

1.0

—

Non-selective monoamine reuptake inhibitors

2.28

1.55

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.96

1.55

1.1

1.0

—

Other and unspecified iron deficiency

2.27

1.55

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.85

1.55

1.0

—

Other disorders of skin and subcutaneous tissue

102

1.74

1.54

1.0

—

Disturbance of activity and attention

2.93

1.54

1.0

—

Diseases of the ear and mastoid process

101

1.59

1.53

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

107

1.61

1.53

1.0

—

Other disorders of bone

2.43

1.53

1.0

—

Chronic diseases of tonsils and adenoids

1.73

1.52

1.0

—

Melanocytic naevi, other sites/unspecified

3.34

1.52

1.0

—

Dilated cardiomyopathy

3.34

1.52

1.0

—

Hernia of abdominal wall, postoperative

3.31

1.51

1.0

—

Substance abuse, excluding more controls

1.93

1.50

1.0

—

Mucosal proctocolitis

2.86

1.50

1.0

—

Cerebral palsy and other paralytic syndromes

2.86

1.50

1.0

—

Melanocytic naevi

2.16

1.50

1.0

—

Actinic keratosis

2.48

1.49

1.0

—

Papulosquamous disorders

2.00

1.48

1.0

—

Mycoses, including avohilmo

122

1.62

1.48

1.0

—

Other external causes of accidental injury

1.72

1.48

1.0

—

Postpartum hemorraghe, all women as controls

2.44

1.48

1.0

—

Inflammatory bowel disease, strict (require KELA)

2.43

1.47

1.0

—

Migraine with aura and triptan purchases

2.50

1.45

1.0

—

Acute and subacute iridocyclitis

2.50

1.45

1.0

—

Other cataract

1.96

1.44

1.1

1.0

—

Visual disturbances and blindness

1.87

1.43

1.1

1.0

—

Implicit viral Sepsis

2.73

1.43

1.0

—

Viral Sepsis

2.73

1.43

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

2.33

1.43

1.0

—

Hypo-osmolality and hyponatraemia

3.10

1.42

1.0

—

Senile cataract

1.78

1.42

1.1

1.0

—

STROKE

1.90

1.40

1.0

—

Postpartum hemorraghe, parous women as controls

2.28

1.40

1.0

—

Dental caries

2.45

1.40

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

121

1.61

1.39

1.0

—

Superficial injury of head

2.41

1.39

1.0

—

Postpartum haemorrhage

2.25

1.38

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.70

1.38

1.0

—

Polycystic ovarian syndrome, consortium definition

1.76

1.36

1.0

—

Somatoform disorder

2.61

1.36

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

2.74

1.36

1.0

1.1

—

Hypertensive Heart Disease

2.68

1.36

1.2

1.0

—

Caries of dentine, including avohilmo

1.73

1.34

1.1

1.0

—

Diabetic maculopathy

2.58

1.34

1.0

—

Disorders of refraction and accommodation

2.13

1.33

1.0

—

Chronic periodontitis, including avohilmo

115

1.55

1.32

1.0

—

Periodontitis

115

1.55

1.32

1.0

—

Pregnancy examination and test

2.66

1.31

1.0

—

Iron deficiency anaemia

1.96

1.31

1.0

—

Other maternal disorders predominantly related to pregnancy

1.82

1.31

1.0

—

Disorders of tooth development and eruption

2.91

1.31

1.0

—

Dental caries, including avohilmo

1.74

1.29

1.1

1.0

—

Injuries to the thorax

1.84

1.29

1.0

—

Other arrhythmias

1.72

1.29

1.0

—

Diplopia

2.78

1.28

1.2

1.0

—

Budesonide

2.78

1.28

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.75

1.27

1.0

—

Complications of medical and surgical care

109

1.65

1.27

1.0

—

Seborrhoeic keratosis

2.29

1.26

1.0

—

Mycoses

2.05

1.26

1.0

—

Cardiomyopathy

2.40

1.24

1.0

—

Injuries to the knee and lower leg

116

1.49

1.24

1.0

—

Generalized anxiety disorder

2.40

1.24

1.0

—

Type 1 diabetes

2.22

1.24

1.0

—

Keratitis

1.96

1.22

1.0

—

Crohn disease

2.63

1.21

1.0

—

Other disorders of breast

2.63

1.21

1.0

1.1

—

Other metabolic disorders

2.63

1.21

1.0

—

Injuries to unspecified part of trunk, limb or body region

2.63

1.21

1.0

1.1

—

Coeliac disease

2.63

1.21

1.0

1.1

—

AV-block

2.67

1.21

1.0

—

Diabetic neuropathy

2.62

1.21

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.67

1.19

1.1

1.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

2.31

1.18

1.0

—

Other menopausal disorders

2.60

1.18

1.0

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

1.79

1.17

1.0

—

Dermatophytosis, including avohilmo

115

1.62

1.16

1.0

—

Obesity

103

1.64

1.16

1.1

1.0

—

Obesity and other hyperalimentation

103

1.64

1.15

1.1

1.0

—

Myopia

2.50

1.15

1.0

—

Other inflammation of eyelid

2.50

1.15

1.0

1.1

—

Endometriosis

2.39

1.13

1.0

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.69

1.13

1.0

—

Cholecystectomy

100

1.61

1.12

1.0

—

Rheumatoid arthritis

2.30

1.11

1.0

—

Dental pulpitis, including avohilmo

111

1.50

1.09

1.0

—

Allergic contact dermatitis

2.38

1.09

1.0

—

Assault

2.38

1.09

1.0

—

Disorders of skin appendages

1.70

1.09

1.0

—

Complications of surgical and medical care, not elsewhere classified

116

1.49

1.09

1.0

—

Other inflammation of eyelid, including avohilmo

1.82

1.08

1.0

—

Maternal care for known or suspected malpresentation of fetus

2.17

1.06

1.0

—

Abnormal findings on diagnostic imaging of lung

1.76

1.06

1.1

1.0

—

Hernia

111

1.50

1.05

1.0

—

Anterior Iridocyclitis

2.12

1.05

1.0

—

Non-ischemic cardiomyopathy

2.13

1.05

1.0

—

Anxiety (asthma-related co-morbidities)

1.64

1.05

1.0

—

Dermatophytosis

2.27

1.03

1.0

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

2.27

1.03

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.96

1.03

1.0

—

Accidents

1.57

1.03

1.0

—

Other diseases of blood and blood-forming organs, wide

2.06

1.02

1.1

1.0

—

Subjective visual disturbances

2.06

1.02

1.0

—

Acute pharyngitis

2.25

1.02

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.72

1.02

1.0

—

Convulsions, not elsewhere classified

2.24

1.01

1.0

—

Diabetes mellitus in pregnancy

1.91

1.01

1.0

—

Presence of cardiac and vascular implants and grafts

1.89

1.00

1.0

—

1.88

1.00

1.0

—

Angina pectoris

1.76

1.00

1.1

1.0

—

Infections with a predominantly sexual mode of transmission

1.88

1.00

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.88

1.00

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.64

1.00

1.1

1.0

—

Disorders of choroid and retina

1.53

1.00

1.0

—

Visual disturbances

1.71

0.98

1.1

1.0

—

Calculus of kidney and ureter

1.84

0.98

1.0

—

Symptoms and signs involving speech and voice

1.84

0.98

1.0

—

Hallux valgus (acquired)

2.00

0.98

1.0

—

Superficial injury of shoulder and upper arm

2.17

0.98

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

1.95

0.97

1.0

—

Substance use, excluding alcohol

1.95

0.97

1.0

—

Personality disorders, excluding more controls

1.94

0.96

1.0

—

Exposure to unspecified factor

122

1.45

0.96

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.85

0.96

1.1

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

1.85

0.96

1.1

1.0

—

Urolithiasis

1.77

0.94

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.91

0.94

1.0

—

Viral warts, including avohilmo

1.89

0.94

1.0

—

Chronic gastritis

1.89

0.94

1.0

—

Medical abortion

1.63

0.94

1.0

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

2.22

0.93

1.0

—

Disorders of vestibular function (Vertigo)

1.72

0.92

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

109

1.45

0.92

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

104

1.45

0.92

1.0

—

Explicit Sepsis, including avohilmo

1.74

0.92

1.1

1.0

—

Insulin, fast-acting

1.82

0.91

1.0

—

All kidney diseases

116

1.44

0.91

1.0

—

Ulcerative colitis (strict definition, require KELA)

2.07

0.89

1.0

—

Conduction disorders

1.88

0.88

1.0

—

Covid-19 confirmed case

1.78

0.87

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

1.86

0.87

1.0

—

Voice disturbances

1.86

0.87

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

1.86

0.87

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.86

0.87

1.1

1.0

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2.00

0.87

1.0

—

Corneal ulcer

2.00

0.87

1.0

—

Haemorrhoids and perianal venous thrombosis

1.85

0.86

1.0

—

Sub-endpoint used in defining T1D endpoints

1.83

0.86

1.0

—

Functional dyspepsia

1.82

0.85

1.0

—

Candidiasis, including avohilmo

1.82

0.85

1.0

—

Redundant prepuce, phimosis and paraphimosis

1.97

0.85

1.0

—

Conjunctivitis (acute, non atopic)

1.81

0.85

1.0

—

All anxiety disorders

1.53

0.85

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.80

0.85

1.0

—

Transient ischemic attack

1.64

0.84

1.0

—

Any death

0.51

0.84

1.0

—

Acute pancreatitis (for exclusion)

1.94

0.84

1.0

—

Primary coxarthrosis, bilateral

1.94

0.84

1.0

—

Sulfasalazine

1.94

0.84

1.0

—

Type 1 diabetes, wide definition, subgroup 1

1.93

0.84

1.0

—

Psoriasis

1.78

0.84

1.0

—

Exposure to other specified factors

124

1.45

0.84

1.0

—

Diseases of the digestive system

1.71

0.84

1.0

—

Alcohol use disorder, Swedish definition

1.57

0.83

1.0

—

Insulin, fast-acting or short human

1.75

0.83

1.0

—

Atopic dermatitis

1.57

0.83

1.0

—

Single spontaneous delivery

1.76

0.82

1.0

—

Delivery

1.76

0.81

1.0

—

Certain disorders involving the immune mechanism

1.88

0.81

1.0

—

Acute pancreatitis

1.88

0.81

1.0

—

Fissure and fistula of anal and rectal regions

1.88

0.81

1.0

—

Type 1 diabetes, wide definition

1.87

0.81

1.0

—

Other strabismus

1.87

0.81

1.0

—

Other anxiety disorders

1.65

0.80

1.0

—

Osteoporosis

1.84

0.79

1.0

—

Other benign neoplasms of skin

1.72

0.79

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.79

0.0

1.0

—

Congenital malformations of the circulatory system

0.00

0.79

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

0.79

0.0

1.0

—

Otitis externa, unspecified

0.00

0.79

0.0

1.0

—

Delivery, wide proxy

1.95

0.77

1.0

1.1

—

Diagnoses used for exclusion with ILD

1.76

0.76

1.0

—

D07AA Corticosteroids, weak (group I)

0.00

0.76

0.0

1.0

—

Seropositive rheumatoid arthritis

2.16

0.76

1.0

—

Diaphragmatic hernia

1.70

0.75

1.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

1.65

0.75

1.0

—

Inflammatory diseases of female pelvic organs

1.53

0.74

1.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

2.08

0.74

1.0

—

Acute nasopharyngitis (common cold)

2.07

0.74

1.0

—

Diverticular disease of intestine

1.49

0.74

1.0

—

Sequelae of external causes of morbidity and mortality

1.84

0.73

1.0

—

Misadventures to patients during surgical and medical care

2.00

0.72

1.0

—

Open wound of lower leg

2.00

0.72

1.0

—

Other skin changes

2.00

0.72

1.0

—

Bacterial Sepsis

1.62

0.72

1.0

—

Benign paroxysmal vertigo

1.80

0.72

1.0

—

Fall on same level involving ice and snow

107

0.56

0.72

1.0

—

Status post-ami

2.00

0.72

1.0

—

Diseases of male genital organs

1.60

0.71

1.0

—

Other septicaemia, including avohilmo

1.59

0.71

1.1

1.0

—

Cardiodefibrillation

1.74

0.71

1.0

—

Haemorrhage in early pregnancy

1.74

0.71

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

1.92

0.70

1.0

—

Acute renal failure

1.92

0.70

1.0

—

Cervicobrachial syndrome

1.92

0.70

1.0

—

Acne, including avohilmo

1.93

0.70

1.0

—

Hypertensive heart and/or renal disease

1.92

0.70

1.2

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

1.71

0.70

1.0

—

All influenza

1.71

0.69

1.1

1.0

—

Strabismus

1.70

0.69

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.49

0.69

1.0

—

FESS (DNB20)

1.85

0.68

1.0

—

Ethmoidectomy

1.85

0.68

1.0

—

Chondropathies

1.85

0.68

1.0

—

Suicide or other Intentional self-harm

1.67

0.68

1.0

—

In situ neoplasms

1.53

0.68

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.44

0.67

1.1

1.0

—

1.44

0.67

1.1

1.0

—

Gonarthrosis,primary

1.38

0.67

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

114

1.36

0.66

1.0

—

Other and unspecified effects of external causes

1.63

0.66

1.0

—

Superficial injury of abdomen, lower back and pelvis

1.79

0.66

1.0

—

All influenza (not pneumonia)

1.79

0.66

1.0

—

Substance abuse

1.47

0.66

1.0

—

Presence of other devices

1.76

0.65

1.2

1.0

—

Polyp of the female genital tract

1.77

0.64

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

1.50

0.63

1.0

—

Codes for special purposes

1.50

0.63

1.0

—

Single delivery by forceps and vacuum extractor

0.00

0.63

0.0

1.0

—

False labour

1.60

0.61

1.0

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.67

0.61

1.0

—

Malignant neoplasm of bronchus and lung

0.00

0.61

0.0

1.0

—

Complications of procedures, not elsewhere classified

111

1.38

0.61

1.0

—

Tonsillectomy and adenotomy

1.45

0.60

1.0

—

Other disorders of kidney and ureter

0.00

0.60

0.0

1.0

—

Poor fetal growth

0.00

0.60

0.0

1.0

—

Explicit Sepsis

1.55

0.59

1.1

1.0

—

Mental and behavioural disorders due to psychoactive substance use

1.43

0.59

1.0

—

Graves disease, strict definition

0.00

0.59

0.0

1.0

—

Panic disorder

0.00

0.59

0.0

1.0

—

Myocardial infarction, with ST-elevation

0.00

0.59

0.0

1.0

—

Colectomy operation

0.00

0.58

0.0

1.0

—

Obstructed labour due to malposition and malpresentation of fetus

1.74

0.58

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

1.71

0.57

1.0

—

Other fall from one level to another

1.71

0.57

1.0

—

Insomnia

115

1.33

0.57

1.0

—

Influenza and pneumonia

118

1.31

0.56

1.0

—

Sleep disorders

114

1.33

0.56

1.0

—

Periapical abscess

0.56

0.55

1.0

—

Diabetic retinopathy

1.51

0.55

1.0

—

Injuries to the elbow and forearm

106

1.37

0.55

1.0

—

1.40

0.54

1.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.58

0.54

1.0

—

Urticaria and erythema

1.50

0.54

1.0

—

Other diseases of anus and rectum

1.57

0.54

1.0

—

Gestational diabetes (for exclusion)

1.47

0.54

1.0

—

Injury of muscle and tendon at shoulder and upper arm level

1.48

0.53

1.0

—

Injuries to the neck

1.50

0.51

1.0

—

Superficial injury of lower leg

1.50

0.51

1.0

—

Malignant neoplasm

1.30

0.49

1.0

—

Malignant neoplasm

1.30

0.49

1.0

—

Bleeding

101

1.32

0.48

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.45

0.47

1.0

—

Diabetic retinopathy, excluding more controls

1.45

0.46

1.0

—

1.37

0.46

1.0

—

Open wound of head

1.41

0.46

1.0

—

Diseases of appendix

123

1.31

0.45

1.0

—

Other disorders of urethra and urinary system

1.37

0.45

1.0

—

Personality disorders

1.40

0.45

1.0

—

Sequelae of cerebrovascular disease

1.39

0.44

1.0

—

Heart failure and bmi 25plus

1.48

0.44

1.0

—

Pregnancy with abortive outcome

1.38

0.43

1.0

—

Infections of the skin and subcutaneous tissue

102

1.35

0.43

1.0

—

Lichen planus, including avohilmo

1.61

0.43

1.0

—

Superficial injury of wrist and hand

1.61

0.43

1.0

—

Pediculosis, acariasis and other infestations, including avohilmo

1.61

0.43

1.0

—

Other septicaemia

1.42

0.42

1.1

1.0

—

Diseases of inner ear

1.38

0.42

1.0

—

Rheumatoid arthritis, including avohilmo

1.40

0.42

1.0

—

Use of hypnotics and sedatives

115

1.24

0.41

1.0

—

Other puerperal infections

0.00

0.41

0.0

1.0

—

Nummular dermatitis

0.00

0.41

0.0

1.0

—

Other infectious diseases, including avohilmo

0.00

0.41

0.0

1.0

—

Colon adenocarcinoma, helper endpoint

0.00

0.41

0.0

1.1

—

Schizoaffective disorder

0.00

0.41

0.0

1.0

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

0.41

0.0

1.1

—

Benign neoplasm: Stomach

0.00

0.41

0.0

1.1

—

Infectious mononucleosis

0.00

0.41

0.0

1.0

—

Infectious mononucleosis, including avohilmo

0.00

0.41

0.0

1.0

—

Glomerulonephritis

0.00

0.41

0.0

1.0

—

Contact with machinery

0.00

0.41

0.0

1.0

—

Enterocolitis due to Clostridium difficile

0.00

0.41

0.0

1.1

—

Medical treatment for female infertility

1.50

0.41

1.0

—

Other and unspecified injuries of lower leg

0.00

0.40

0.0

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.00

0.40

0.0

1.0

—

Abnormal spermatozoa

0.00

0.40

0.0

1.0

—

Pleural effusion

0.00

0.40

0.0

1.1

—

Ulcer of lower limb, not elsewhere classified

0.00

0.40

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.40

0.0

1.0

—

Hypotension

0.00

0.40

0.0

1.1

—

Other and unspecified urticaria

1.47

0.40

1.0

—

Benign neoplasm of major salivary glands

0.00

0.40

0.0

1.1

—

Benign mammary dysplasia

0.00

0.40

0.0

1.1

—

Secondary uncertain malignant neoplasm

0.00

0.40

0.0

1.0

—

Other diseases of pleura

1.31

0.39

1.0

—

Insulin, intermediate and long-acting

1.36

0.39

1.1

1.0

—

Fracture of skull and facial bones

1.43

0.39

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

0.39

0.0

1.1

—

HSIL lesion of the cervix uteri, vagina or vulva

1.39

0.38

1.0

—

Other viral diseases, including avohilmo

1.35

0.38

1.0

—

Appendectomy

119

1.28

0.36

1.0

—

Maternal care for other known or suspected fetal problems

1.45

0.36

1.0

—

Falls/tendency to fall

1.23

0.36

1.0

—

Gestational [pregnancy-induced] hypertension

1.46

0.36

1.0

—

Intestinal stricture

1.40

0.35

1.0

—

Unspecified fall

1.35

0.35

1.0

—

Colonic or urogenital fistula

1.36

0.34

1.0

—

Insulin medication

1.33

0.34

1.1

1.0

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

107

1.28

0.34

1.0

—

Appendicitis, broad definition

123

1.24

0.31

1.0

—

Stroke, including SAH

0.70

0.31

1.0

—

Varicose veins

1.29

0.31

1.0

—

Diseases of salivary glands

1.35

0.31

1.0

—

Other viral diseases, not elsewhere classified, including avohilmo

1.34

0.31

1.0

—

Erysipelas

0.71

0.31

1.0

—

Bacterial infection, other or unspecified, including avohilmo

0.70

0.31

1.1

1.0

—

Renal tubulo-interstitial diseases

107

1.23

0.31

1.0

—

Other diseases of lip and oral mucosa

1.33

0.30

1.0

—

Obesity, other/unspecified

1.27

0.30

1.1

1.0

—

Implicit bacterial Sepsis, including avohilmo

1.27

0.30

1.0

—

Chronic apical periodontitis

118

1.19

0.30

1.0

—

Complications of labour and delivery

1.29

0.29

1.0

—

Acute appendicitis

120

1.24

0.29

1.0

—

Other and unspecified tonsillitis

1.24

0.29

1.0

—

Hyperplasia of prostate

1.29

0.28

1.0

—

Solid cancers

1.21

0.28

1.1

1.0

—

Artificial joint operation, meniscal resection

106

1.21

0.28

1.0

—

Degeneration of macula and posterior pole

1.29

0.28

1.0

—

Septicaemia

1.28

0.28

1.1

1.0

—

Zoster [herpes zoster], including avohilmo

1.29

0.28

1.1

1.0

—

Malignant neoplasm, wide definition

102

1.20

0.27

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.27

0.27

1.0

—

Gonarthrosis, primary, with knee surgery

1.28

0.27

1.0

—

Venous thromboembolism

1.29

0.27

1.0

—

DVT of lower extremities and pulmonary embolism

1.24

0.27

1.0

—

Other disorders of veins

1.23

0.27

1.0

—

Renal failure

1.22

0.27

1.0

—

Abrasion of teeth

1.21

0.26

1.0

—

Aplastic and other anaemias

1.20

0.26

1.0

—

Acute tubulo-interstitial nephritis

1.27

0.26

1.0

—

Necrosis of pulp, including avohilmo

112

1.23

0.26

1.0

—

Malignant neoplasm, including Hilmo

103

1.19

0.26

1.0

—

Spontaneous abortion

1.20

0.25

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

0.71

0.24

1.2

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

123

1.17

0.23

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1.32

0.23

1.0

—

Other/unspecified seropositive rheumatoid arthritis

1.32

0.23

1.0

—

Combinations of oral blood glucose lowering drugs

1.32

0.23

1.0

—

Seropositive rheumatoid arthritis, wide

1.28

0.23

1.0

—

Pulmonary heart disease

1.28

0.23

1.0

—

Stroke, excluding SAH

0.73

0.22

1.0

—

All pneumoniae

123

1.16

0.22

1.0

—

Poisoning by medicine

1.25

0.22

1.0

—

Pulmonary embolism

1.25

0.22

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

101

1.22

0.22

1.0

—

Lung cancer and mesothelioma

0.00

0.21

0.0

1.0

—

All dysplastic lesions of the cervix uteri

1.20

0.21

1.0

—

Childhood allergy (age < 16)

0.00

0.21

0.0

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

1.19

0.21

1.0

—

Sleep disorders, other/unspecified

0.00

0.21

0.0

1.0

—

Contact with heat and hot substances

0.00

0.21

0.0

1.0

—

Chronic suppurative otitis media

0.00

0.21

0.0

1.0

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.21

0.0

1.0

—

Other infective otitis externa

0.00

0.21

0.0

1.0

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.21

0.0

1.1

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

0.00

0.21

0.0

1.0

—

Foreign body or object entering through skin

0.00

0.21

0.0

1.0

—

Benign neoplasm: Choroid

0.00

0.21

0.0

1.1

—

Acute peritonitis

0.00

0.21

0.0

1.0

—

Other/unspecified reactive arthropathies

0.00

0.21

0.0

1.0

—

Injury of other and unspecified intrathoracic organs

0.00

0.21

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS